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ABSTRACT
Introduction Epilepsy is a common neurological condition 
affecting between 3% and 3.5% of the Australian 
population at some point in their lifetime. The effective 
management of chronic and complex conditions such 
as epilepsy requires person- centred and coordinated 
care across sectors, from primary to tertiary healthcare. 
Internationally, epilepsy nurse specialists are frequently 
identified as playing a vital role in improving the integration 
of epilepsy care and enhancing patient self- management. 
This workforce has not been the focus of research in 
Australia to date.
Methods and analysis This multistage mixed- method 
study examines the role and responsibilities of epilepsy 
nurses, particularly in primary and community care 
settings, across Australia, including through the provision 
of a nurse helpline service. A nationwide sample of 
30 epilepsy nurses will be purposively recruited via 
advertisements distributed by epilepsy organisations 
and through word- of- mouth snowball sampling. Two 
stages (1 and 3) consist of a demographic questionnaire 
and semistructured interviews (individual or group) 
with epilepsy nurse participants, with the thematic data 
analysis from this work informing the areas for focus in 
stage 3. Stage 2 comprises of a retrospective descriptive 
analysis of phone call data from Epilepsy Action Australia’s 
National Epilepsy Line service to identify types of users, 
their needs and reasons for using the service, and to 
characterise the range of activities undertaken by the 
nurse call takers.
Ethics and dissemination Ethics approval for this 
study was granted by Macquarie University (HREC: 
52020668117612). Findings of the study will be published 
through peer- reviewed journal articles and summary 
reports to key stakeholders, and disseminated through 
public forums and academic conference presentations. 
Study findings will also be communicated to people living 
with epilepsy and families.
BACKGROUND
The common neurological condition, 
epilepsy, affects an estimated 65 million 
people worldwide.1 In Australia, some 
0.6% of the population live with epilepsy, 
and between 3% and 3.5% will experience 
epilepsy at some point in their lifetime, with 
14 000 new diagnoses each year.2 Approxi-
mately one- third are diagnosed with refrac-
tory epilepsy (also known as drug- resistant 
epilepsy), where seizures persist and seizure 
freedom cannot be successfully attained 
through antiepileptic drugs.3 Alongside drug 
therapy, a range of surgical treatment options 
are available in Australia and a recent system-
atic review found an increased possibility of 
seizure freedom with ‘resective brain surgery’ 
(median 62.4%) for some people with drug- 
resistant epilepsy.4–6 However, in Australia as 
elsewhere, surgery is critically underused.
Delayed care
Successful surgery can be life- changing, 
according to individual accounts,7 but delays 
in surgical intervention and other treatment 
options are apparent (approximately 17 years 
Strengths and limitations of this study
 ► In- depth interviews/focus groups will encourage a 
detailed, thorough examination of epilepsy nurse 
(EN) roles and responsibilities in supporting people 
living with epilepsy.
 ► Findings from the thematic analysis of the interviews 
will be interpreted in conjunction with the findings of 
the National Epilepsy Line data analysis to identi-
fy the circumstances that lead to people accessing 
more individualised EN support.
 ► The level of detail disclosed will lend itself to the 
consideration of roles and responsibilities of nurses 
in other care settings.
 ► Small- scale, mixed- method investigation has limita-
tions for replicability.
 ► The role and responsibilities of the EN are from the 
perspectives of nurses only.
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in Australia; 22 years in the USA).8 This can place an exces-
sive burden on people living with epilepsy (PLWE) in terms 
of mental and physical health and well- being. In addition, 
disease manifestations often include cognitive and/or psychi-
atric comorbidities, which are frequently exacerbated by 
disease misdiagnosis and inappropriate treatments, particu-
larly in community and primary contexts.9 Thus, by the time 
many PLWE arrive at specialist Tertiary Epilepsy Centres 
(TECs), they can have psychosocial comorbidities limiting 
the potential benefits of surgery and other treatments.10 11
Delays in appropriate treatment and seizure management 
are experienced by people living with all types of epilepsies 
(including the newly diagnosed and those with complex 
epilepsy). These delays can impact PLWE and their fami-
lies, with sustained retention in primary and community 
care sectors leading to system bottlenecks as people wait for 
specialist care.3 9 As healthcare resources (eg, staffing) are 
stretched by growing demand on services, and people staying 
within primary, community or tertiary care not being moved 
on through the service (or those arriving in TECs staying 
too long under specialist care), there are growing concerns 
about a lack of integrated services.
Research investigation
Work being undertaken by a group of epilepsy researchers, 
implementation scientists and clinical specialists in New 
South Wales, Australia, has led to new knowledge about 
health service use by PLWE. Our team has examined 
service delays in care delivery8 9 12 and through an eight- 
phased research programme (2016–2020; figure 1) 
collected data about individual experience and service use 
through epidemiological studies, patient medical record 
reviews, and studies examining quality of life and patient 
need using narrative, textual and observational material. 
The programme has revealed a clear correlation between 
service delays and physical, mental and psychosocial dete-
rioration, pervasive across adult groups. Service delays 
can affect decision- making, shared care and patient infor-
mation provision.9 Indecision is also an issue for patients, 
exacerbated by care fragmentation,9 13 lengthy waits,1 14 
the need to navigate complex systems,1 9 12 lack of patient- 
focused care,9 professional misunderstanding,9 12 health-
care professionals’ (HCPs) limited access to information9 
and inadequate resourcing (staff and financing).12
Research implications
The research programme benefitted from patient 
involvement, while service- user organisations supported 
access to community services. To date, outcomes have 
been largely framed by the patient- reported determinants 
of health and well- being model (the Patient Reported, 
ImpleMentation sciencE model13), offering new evidence 
around patients’ sense of self and physical and emotional 
well- being.9 13 Clinical audits and epidemiological assess-
ment of service use and mortality rates8 14 have also 
Figure 1 The eight- phased research programme in refractory epilepsy (2016–2020).
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indicated adjustments needed to improve care, alongside 
evaluations of professional practice at different stages 
in the patient journey9 : information- sharing; patient 
throughput and professional collaboration. For example, 
having examined the pressure that system bottlenecks 
place on TECs, we discovered a range of resource impacts 
where hospitals reject new referrals (in part, resulting 
from a lack of clinical space to meet demand). We also 
noted patients’ unwillingness to transition out of TECs 
back into the community setting, suggesting concerns 
regarding community practitioners’ capacity for patient 
support.9 14
Epilepsy nurses
Drawing on foundational concepts in implementation 
science as the theoretical basis for our work,15 we have 
relied heavily on the views of PLWE, epileptologists, 
general neurologists, neurosurgeons, primary care practi-
tioners and neuropsychologists to inform our knowledge 
base. The literature echoes this reliance, indicating a lack 
of information surrounding family, carer and friends’ 
views and their experiences of care quality.
In addition, the voices of Australian epilepsy nurses 
(ENs) are lacking in the literature. We know that ENs 
can interact with people who experience seizure activity 
at various stages of treatment and care, working across 
primary, community and tertiary practices, emergency 
departments, neurology wards, outpatient clinics, private 
specialist rooms, and the general community in private, 
government and not- for- profit service organisations. 
However, we do not know their views of interactions with 
PLWE, interprofessional care relationships, their sense 
of responsibility for working with others, their ability to 
educate and inform to alleviate patient frustration, and 
create realistic expectations for patients and families.
We also know little of their role in person- centred 
management (with refractory epilepsy and other types 
of epilepsy), or of providing advice to PLWE at different 
stages of diagnosis and care. We also know little of their 
integrated role in epilepsy care and management plan-
ning. This, in spite of a growing recognition of the benefit 
of nurse investment in improving chronic disease manage-
ment and mental health in primary care settings.16–18 We 
recognise, from research undertaken in other countries 
such as the UK, Ireland, France, Canada and the USA, 
that ENs may be a pivotal element of integrated care, 
supporting service access, self- management, advocacy 
and expert disease knowledge.19–22 However, research 
evidence from elsewhere, including Australia, is lacking 
or missing.19
According to the 2008 Western Australia Epilepsy 
Services Model of Care,23 the EN is a vital player in 
ensuring patients' smooth transition through the health 
system. The UK’s National Institute of Clinical Excel-
lence (NICE) guidelines indicate that ENs influence 
access for PLWE, not only to suitable clinical services, but 
also to other services, including social care and counsel-
ling services.24 In addition, we know that ENs can join 
physicians to provide more timely access to advice that is 
important in the paroxysmal expression of seizure disor-
ders. Their role, in both community and tertiary settings, 
also helps PLWE and their families interpret and act on 
test results. The NICE guidelines24 aim to ensure that all 
PLWE are seen between scheduled clinical reviews and 
supported effectively in the community for improved 
person- centred outcomes. Moreover, despite the small 
number of EN specialist nurses in the UK, the NICE 
guidelines attempt to systematise contact with PLWE, 
ensuring they are seen at diagnosis and receive ongoing 
EN review, before and after clinical consultation.
Fitzsimons et al21 examined evidence- based models of 
care for PLWE in Ireland, finding the EN role to be one 
of education: empowerment to self- manage and improve-
ment to the integration of care. Fitzsimons et al note that 
the impact of nurse interventions on health outcomes 
such as seizure frequency, health service use and cost is 
a subject largely unexplored, with limited opportunities 
for generalisability across nurse interventions regarding 
intervention effect.21 Nevertheless, Fitzsimons et al21 make 
a strong case for the pivotal position of the EN in empow-
ering patients and enhancing integration of epilepsy 
care. In addition, Higgins et al22 25 provide evidence of the 
EN’s leading role in the progression of evidence- based 
care underpinning service delivery across organisations 
and sectors.
As highlighted in a recent mapping review, the EN 
role, originally established in the UK, has since evolved 
in many ways across different locations, including 
further specialisations in areas such as paediatrics and 
prescribing.19 However, these developments have by 
no means influenced applications in other parts of the 
world, with a lack of systematic development of this role 
worldwide.19 20 Indeed, many countries do not have ENs. 
In Australia, while the role does exist, research has yet 
to investigate its significance as part of community initia-
tives; as well as role acceptability and differentiation, 
nurse responsibilities, and frequency of contact with 
PLWE and families between scheduled clinical reviews. 
Research in Australia has yet to assess the EN role, the 
varied groups ENs support and those whose needs are not 
being met as a result of current models of practice. There 
is also the need to examine which elements of their role 
contribute to effective delivery of person- centred care. It 
is recognised globally that ENs have an important role to 
play in a multidisciplinary team, in advocacy and advice 
giving, continuity of care, self- management programmes, 
educational provision for statutory and voluntary organ-
isations, and sharing of expert knowledge; but more 
research is required to standardise and develop their 
roles.19 20 26
This protocol aims to clarify the EN network within 
Australia including interprofessional connections, as 
well as the EN’s influence on the well- being and care of 
PLWE, and EN relationships with families and others as 
there is little standardised information in Australia about 
EN roles and qualifications or nationally standardised 
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training programmes. It will also provide insights into 
Australian service delivery. Due to the broad contexts 
in which ENs and PLWE intersect, we will primarily 
explore the elements of their roles and responsibilities 
that apply to working in primary and community settings. 
Knowledge gained will highlight the capacity for ENs to 
respond to PLWE, their families, other HCPs and changes 
in service delivery, particularly relevant under the current 
COVID-19 public health crisis (see figure 2 for a synthesis 




Clarify the Australian EN role in supporting PLWE, 
contributing to future developments of the role and 
advancing integrated care.
 ► Assess the role and responsibilities of the EN across 
Australia for people living with all types of epilepsies 
in the community, including the newly diagnosed and 
those with well- controlled epilepsy, but with particular 
reference to refractory epilepsy.
 ► Define community EN services including the National 
Epilepsy Line (NEL) (Epilepsy Action Australia/
EAA),27 taking account of characteristics of caller 
need and call outcomes.
Objectives
 ► Clearly articulate the essential elements of the EN 
role and responsibilities in the Australian context, 
particularly in primary and community care settings.
 ► Understand the EN experience of intersections 
between primary, community and tertiary care while 
supporting shared care, inter- professional disease 
management and efficient patient transitions to TECs.
 ► Identify EN career pathways, qualifications, training 
and work experience.
 ► Clarify EN contributions during a public health crisis 
(eg, COVID-19) to strengthen service responses at 
times of crisis.
METHODS
A three- staged, mixed- method study28 will involve 
semistructured interviews (or where preferable, focus 
groups) with EN participants using interview schedules 
to generate rich data. Iterative, thematic data analysis 
will build an understanding of the EN role as new data 
are collected,29 enhanced by a retrospective descriptive 
statistical analysis30 of de- identified phone calls from the 
EAA NEL, (the only helpline in Australia to employ solely 
ENs).27 Together, datasets will provide evidence of the 
significance of the EN role, with a focus on community 
and primary care. Researcher fieldnotes will accompany 
qualitative data capture, clarifying dynamic participant 
interactions. Data will illuminate EN roles and respon-
sibilities, workloads and relationships with community 
stakeholders (clinical and non- clinical, for example, 
statutory bodies, members and voluntary organisations). 
Participant demographic data will clarify the EN’s place of 
work, work characteristics, gender, years of experience in 
nursing overall and in epilepsy, qualifications, role, role 
title, employer, age and so on. EAA will provide de- identi-
fied NEL data for analysis.
Patient and public involvement
The involvement of PLWE in earlier studies conducted by 
the research team informed the development and design 
of this study.
Sample, recruitment and ethical considerations of participant 
retention
An estimated 60 mixed- method data- capture events will 
take place alongside data from the NEL call log. Thirty 
EN participants will be involved nationwide:
 ► Stage 1: 20 interview transcripts.
 ► Stage 2: call data from the EAA NEL.
 ► Stage 3: 10 interview transcripts (or 2 focus group 
transcripts).
 ► Stages 1 and 2: 30 demographic questionnaires.
 ► Stages 1 and 3: fieldnotes.
 
3. Examine EN role in education and 
training: 
• PLWE and families 
• Schools 
• Community groups and organisations 
• HCPs 
• Others requesting training/ information 
 
 
1. To gather evidence on elements of the 
EN role relating to primary and 
community care settings: 
• Describe role/ responsibilities from EN 
perspective 
• Views of shared care, care coordination 
and self-management  
• Capacity to collaborate across 
organisations and sectors for more 
connected care and support 
• Influence on future development of the 
role    
2. Explore the EN role with helplines:  
• Epilepsy Action Australia (sole 
contributor of data from the Epilepsy 
Nurse Line (ENL)) will provide 
deidentified ENL call data for 
descriptive statistical analysis 
• ENs from across Australia will provide 
additional insights into their role on 





















Topics where queries about the Epilepsy Nurse role remain: 
• Role and responsibilities and contexts in which ENs are recognised? 
• Range of responsibilities in each context? 
• Relationships with general practitioners, other nurses, emergency department medical teams, general neurologists, 
epileptologists, and others offering healthcare, social care and community support across primary, community and 
tertiary care? 
• Impact of epilepsy helplines and EN advice on care, healthcare pathways and shared care? 
• Has an evidence-base for epilepsy helplines been identified? 
• Perceptions of relationships between hospital and community epilepsy nurses? 
• Effect of ENs on patient self-management/information acquisition/decision-making? 
• Support ENs offer PLWE and employers for safe working and employment? 
• Role of EN at time of first diagnosis, and diagnosis of refractory epilepsy? 
• Support for those who are homeless or of lower socioeconomic status? 
• Role in home visits, in health promotion and in offering psychosocial support?  
• Approach to risk education, e.g., avoidable deaths in epilepsy?  
• How EN services are designed, managed and rolled-out across settings? 
• Snapshot of number/frequency/service type/component-spread across location/state? 
• Educational role in group training, community support, online/face-to-face courses? 
• Role in National Disability Insurance Scheme (NDIS), My Aged Care, Integrated Carer Support Services (ICSS)? 
• Support of Aboriginal and ethnic minority population groups? 
• Impact/potential impact of COVID-19 on the role and responsibilities of the EN? 
Figure 2 Generating knowledge and understanding of 
EN arrangements in Australia. EN, epilepsy nurse; HCPs, 
healthcare professionals; PLWE, people living with epilepsy.
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Participants will be recruited purposively to ensure data 
collection from ENs working across: (1) metropolitan, 
(2) inner regional and (3) outer regional/rural/remote 
locations, with a mix of nurses who support a wide PLWE 
demographic. Work locations will be defined by the 
Australian Statistical Geographical Standard Remoteness 
Area and Statistical Area Level 2.31 A purposive partici-
pant sample will enable the representation of different 
participant perspectives while identifying any geographi-
cally sensitive issues affecting care and services. Inclusion: 
all participants currently in an EN role working within 
Australia. Exclusion: ENs involved in clinical trials or 
working outside primary and/or community care settings.
EN participants will be recruited nationwide, with 
support from team members. Recruitment will take advan-
tage of current partnerships with EAA, Epilepsy Australia 
(EA) and EA partners: Epilepsy Australian Capital Terri-
tory; Epilepsy Foundation (EF); Epilepsy Queensland; 
Epilepsy Tasmania; Epilepsy Western Australia; and the 
Epilepsy South Australia and Northern Territory. Adver-
tisements will be distributed via social media channels, 
local and national nurse professional organisations, and 
through newsletters and flyers. The recruitment strategy 
will also involve snowball sampling, where recruited partic-
ipants are encouraged to invite colleagues to contact the 
research team to participate. This combination of recruit-
ment channels will encourage a comprehensive data 
collection. Potential participants will be provided with a 
Participant Information and Consent Form (PICF) with 
data management and handling requirements, retention 
of confidential data, data collection and analysis. Study 
reporting processes will be included, and potential partic-
ipants will be given the opportunity to ask questions. A 
2- week consent turnaround will allow people to consider 
their involvement. Following a signed returned consent 
form, recruitment will commence. All participants will 
be fully informed of their rights, including the option to 
withdraw from the study at any time without reason, the 
ethical implications of participation and study plans for 
data dissemination.
Data collection
Following ethical approval and participant consent, 
4 months of data collection will take place in three stages 
(see below; table 1).
Stage 1: 20 semistructured telephone, face-to-face or video-
conference interviews with ENs across Australia and completion of 
a demographic questionnaire
Two pilot interviews will pretest the interview schedule 
(which was derived from a search of the literature19 20 22) 
and feedback from pilot data will be used to tailor the 
final interview schedule. A demographic questionnaire 
alongside the interviews will collect details of ENs’ work 
location, role, training and training needs, models of 
service delivery, responsibilities, gender, age range, scope 
of work and current practices and working arrangements, 
education and setting. A 1- hour interview with each of 
the 20 participants will allow for a detailed conversation 
with a dedicated study researcher. Interviews will be audio 
recorded, de- identified and transcribed. Fieldnotes will 
be taken describing interview dynamics and collated in a 
researcher diary.
Interviews will cover the following topics:
EN career pathway, role/responsibilities in community 
and primary care contexts (particularly for people with 
refractory epilepsy, by no means exclusively limited to 
this group of patients as ENs in this setting also deal with 
new diagnosis cases and those with less chronic seizure 
disorders), experiences during COVID-19 pandemic, 
interactions and relationships with PLWE and families, 
interprofessional dynamics, information- sharing, family 
involvement, opportunities for shared decision- making, 
educational roles, involvement in epilepsy helplines, 
advocacy, who is accessing EN services and why, what 
ENs hope to achieve from consultations, service regu-
larity and scrutiny, and liaison across healthcare profes-
sional groups. Schedules will concentrate on how nurses 
respond to the needs of PLWE (whom they meet face- to- 
face, through the NEL or other communication avenues), 
how information is shared about the needs of PLWE with 
other HCPs, and whether the epilepsy nurse plays a stra-
tegic role in shared care. Consequently schedules do not 
include topics such as audit or prescribing.
Schedule prompts will allow nurses to diversify from set 
questions if desired, and ENs may also discuss social care 
including services provided under National Disability 
Insurance Scheme, My Aged Care, and Integrated Carer 
Support Service, educational events and group activities, 
policy guidance, research activities and the evidence base 
for roles.
Data analysis
Qualitative data (interview transcripts/focus group tran-
scripts/researcher fieldnotes) will be analysed themati-
cally in accordance with study aims and objectives.29 An 
inductive thematic analysis approach will involve the 
verbatim transcription of all data to identify themes and 
their concomitant categories. Following a period of famil-
iarisation with the data, an inductive thematic analysis 
will be undertaken by three analysts working first indi-
vidually and then together (a primary analyst (KH) and 
two secondary analysts (TR and RN)). They will consider 
responses to questions, patterns of speech, and irregular-
ities or issues that appear important or contrary. Induc-
tive thematic analysis is undertaken in a staged manner to 
ensure a thorough understanding of data as they arrive. 
Once individual readings have taken place, primary and 
secondary coders will use NVivo32 to develop a coding 
framework. Teamwork will allow analysts to review codes 
to refine the thematic framework. The technique has 
been extensively applied in other published team studies9 
adding to the veracity and rigour of the technique.33 Data 
will be inductively coded until saturation is achieved as a 
means of identifying meaningful units of text.29 Qualita-
tive findings will be triangulated with EN questionnaire 
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information for the purpose of corroboration, and with 
the results of the NEL data analysis for elaboration and 
expansion.28
Stage 2: examination of call logs (to understand what the nurse 
does and how this shapes their overall role): EAA’s NEL
A retrospective study of phone calls made to the EAA 
NEL service from 1 June 2019 to date of commencement 
of study will take place. The NEL is a phone and email 
service available daily, 09:00–17:00, to individuals nation-
wide. The service is overseen by EAA and aims to improve 
health outcomes and support PLWE and families.27 It is 
an important part of nurse- led activity. Information is 
collected about each phone call, reason for the call (eg, 
daily living, seizure history and management, medical/
health, emotional/social, recreation/leisure, employ-
ment and other) and any additional topics (that may 
include reasons for the call, basic epilepsy information 
and actions by call taker). EAA will provide de- identified 
data for descriptive statistical analysis.
Stage 2 will also enable the team to describe the charac-
teristics of caller needs, call outcomes and any impact of 
the COVID-19 pandemic on call type and frequency. This 
will be achieved through three aims:
 ► Identify and describe the reason for the call.
 ► Characterise the actions taken by call taker, for 
example, referring callers to an EN for follow- up and 
Table 1 Study outline: stages 1–3
Stage 1 Participants Process
Australia- wide semistructured 
interviews
n=20 individual ENs Advertising through EAA, EF, EA and EA partner organisations, social 
media, snowballing, word of mouth, nurse- specific organisations, etc.
Demographic questionnaire
  Inclusion: ENs working in Australia. PICF and demographic questionnaire provided and completed by all 
participants before interview.
  Exclusion: ENs involved in clinical 
trials only or working outside primary 
and/or community care settings.
Interviews (approximately 60- minute duration) conducted face- to- face 
(workplace, clinic or venue agreed by participant and researcher), 
over the telephone or via video- conferencing. Interviews will be audio 
recorded, de- identified and transcribed. Fieldnotes will be taken 
(dynamics of interactions) and collated in a research diary.
  Australia- wide cohort. A thematic analysis29 will be conducted on all qualitative data.
Stage 2 Data Process
Retrospective examination of call 
logs from EAA’s NEL
De- identified descriptive data will be 
obtained from NEL calls logged from 
1 June 2019 to commencement of 
the study.
Letter providing consent from EAA for main university site to access 
and analyse de- identified data.
  Where appropriate, confounding 
factors will be adjusted in the 
analysis. Where adjustment is not 
possible, sensitivity analyses will be 
performed.
Conduct descriptive statistical analysis using software (such as SPSS 
or SAS).30 Cluster analysis will identify distinct groups of NEL users 
and correspondence analysis to describe relationship among variables 
(eg, caller needs, characteristics, call outcomes).
Stage 3 Participants Process
Australia- wide semistructured 
interviews (embellish data from 
stages 1 and 2)
10 data collection events (video- 
conferencing or face- to- face 
interviews) and/or up to two focus 
groups (depending on results from 
previous stages.
Advertising through EAA, EF, EA and EA partner organisations, social 
media, snowballing, word of mouth, nurse- specific organisations, etc.
Demographic questionnaire 
(unless already completed in 
stage 1)
This may include a mix of 
participants who have agreed to be 
reinterviewed from stage 1 and new 
participants.
  Inclusion: ENs working in Australia. PICF and demographic questionnaire form provided and completed 
by all participants before interviews (unless already completed in 
stage 1).
  Exclusion: ENs involved in clinical 
trials only, or not working in primary 
or community care settings.
Interviews or focus groups conducted face- to- face (workplace, 
clinic or venue agreed by participant and researcher), or via video- 
conferencing. Interviews/ focus groups will be audio recorded, 
transcribed and de- identified. Fieldnotes taken by researcher collated 
in a research diary.
  Australia- wide cohort. Thematic analysis29 of the interview and/or focus group data and 
researcher fieldnotes.
EA, Epilepsy Australia; EAA, Epilepsy Action Australia; EF, Epilepsy Foundation; ENs, epilepsy nurses; NEL, National Epilepsy Line; PICF, Participant 
Information and Consent Form.
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the breadth of information directly provided to callers 
(eg, seizure management, employment, medication).
 ► Identify any changes in types and frequency of calls 
since a state of emergency was announced on 16 
March 2020 by the Australian government (pandemic 
related).
Identifying the differences between callers who are 
referred to an EN for follow- up and those who are not 
will aid interpretation of the interviews and expand on 
the qualitative findings by uncovering where (ie, for who 
and for what needs) the support of ENs may be in greater 
demand.
Stage 3: 10 follow-up interviews (or 2 focus groups) (10 data 
collection events in total) and the completion of a demographic 
questionnaire
Stage 3 is intended to ensure the thematic accuracy of 
the data analysed to date. During stage 3, involvement 
of a national cohort of 10 EN participants will enable us 
to delve deeper into and embellish themes generated 
during stages 1 and 2. Face- to- face, telephone or online 
interviews (or two online focus groups) will be conducted 
(depending on findings from the earlier stages). As in 
earlier stages, interviews will be audio recorded, de- iden-
tified and transcribed. Fieldnotes will be taken, and 
all qualitative data analysed thematically. Stage 3 will 
provide additional knowledge and understanding of the 
approaches adopted to support PLWE (including those 
with refractory epilepsy), and adherence to policy guide-
lines. Stage 3 will provide the opportunity to explore 
the potential for EN role development towards a more 
streamlined model of care. EAA, EF, EA and EA partner 
organisations and snowball sampling with stage 1 partic-
ipants will support recruitment. Similar ethical consider-
ations and consent requirements will apply.
Participant recruitment and ethical considerations
Before data collection, participants in the interviews (and 
if appropriate, focus groups) will be asked to read and 
sign a PICF, retain a copy and return the original to the 
study team. A dedicated study researcher oversees data 
collection and analysis activities, ensuring due consider-
ation is given to safeguarding participants against risk, 
harm and discomfort. The researcher will be appro-
priately supported by a research team with expertise in 
refractory epilepsy research, implementation science and 
clinical practice. With regard to stage 2, EAA own the data 
relating to the NEL and will provide the research team 
with de- identified data which protect the anonymity of 
NEL users.
Epilepsy organisations nationwide fully support the 
study, and international clinical input will aid data inter-
pretation and reporting on a global scale. Community 
links with nurse contacts and epilepsy organisations 
will aid recruitment and promote the research through 
networks and newsletter, while expert advice on the role 
of ENs nationwide will support knowledge translation 
and effectiveness, promoting research findings through 
networks and newsletters.
All materials will be de- identified, with pseudonyms 
used for participants involved in data reporting. Work-
place settings and services will also be anonymised for 
de- identification purposes, including any data containing 
verbatim quotations.
The dedicated study researcher will oversee all data 
collection, analysis, collation, storage and retention 
while being supported to advance the study write- up and 
dissemination. Data will be held at the lead university 
site. Electronic data will be stored in password- protected 
computers with de- identified data blinded for peer review 
and accessible only to core team members and the dedi-
cated study researcher.
ETHICS AND DISSEMINATION
Ethics approval for this study was granted by Macquarie 
University (HREC: 52020668117612). Findings of the 
study will be published through peer- reviewed journal 
articles and summary reports to key stakeholders, and 
disseminated through public forums and academic 
conference presentations. Study findings will also be 
communicated to PLWE and families.
Impact
Improvements to health and social care services for PLWE 
and their families are envisaged, including:
1. Improved understanding of EN services, EN qualifi-
cations and training, and the provision of services in 
primary and community settings.
2. Enhanced knowledge of nurse management strategies 
for PLWE and through use of the NEL.
3. Comprehension of EN responsibilities during a pub-
lic health crisis: identifying potential opportunities for 
changing and sharing roles during a crisis.
4. Clarity over untapped resources.
5. Greater understanding of the types of work demands 
on the EN and community services, and the degree to 
which nurses interact with other HCPs across health 
and social care (eg, EAA, EA).
6. Relationships among organisations nationwide and be-
tween researchers and advocacy groups.
Wide dissemination and study reporting (publications, 
presentations at national conferences and an executive 
summary) will identify how data enhance current knowl-
edge and understanding of nurse roles and responsibili-
ties, PLWE journeys through care and interprofessional 
relations. In addition, study reports will be shared with 
academic, professional and other stakeholder audi-
ences (eg, community epilepsy organisations) to high-
light what has been learnt about epilepsy management 
in the Australian community setting and perceptions of 
responsibilities.
Implications
The effective management of all epilepsies, with 
particular reference to drug- resistant epilepsy but not 
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exclusively limited to this, can be influenced by a lack of 
integrated care across primary, community and tertiary 
contexts. EN professionals are perceived to play a critical 
role in linkage and liaison with PLWE, families, social care 
support services, primary and community HCPs, educa-
tors and specialist epilepsy professionals, but this has not 
been investigated in Australia to date, with little research 
elsewhere. Establishing better shared care pathways and 
integrated models of care will ensure more informed 
and involved PLWE with the potential for a reduction 
in referral delays, and more effective, safe transitions 
through health and social care systems. The opportunity 
to explore the EN role before, during and immediately 
following the COVID-19 public health crisis offers an 
additional and unique opportunity to develop new collab-
orations and demonstrate the significance of the EN role 
at a time of unprecedented challenge to health and social 
care sectors.
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